Medicines in China’s National Health Insurance System

Discover the intricacies of China's healthcare landscape with Medicines in China’s National Health Insurance System, authored by the dedicated team at Zhongguo fa zhan yan jiu ji jin hui Staff. This insightful publication, set to be released in 2024 by Taylor & Francis Ltd, delves into the selection, procurement, and pricing of medicines within China's National Health Insurance framework. With a comprehensive analysis of reimbursement systems, drug prescribing practices, and the influence of commercial insurance on medication costs, this book is an essential resource for anyone interested in public health and healthcare policy. Spanning numerous pages of valuable information, it offers a thorough examination of how these elements interact to shape healthcare delivery in one of the world's largest countries. Don't miss the opportunity to enhance your understanding of this critical topic!